These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 525026)

  • 1. [Use of a fractionated ESR and ESR in Matliev's modification for evaluating body reactivity and treatment effectiveness in the late form of porphyria cutanea].
    Tsygankova EP
    Vestn Dermatol Venerol; 1979 Dec; (12):49-51. PubMed ID: 525026
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal dialysis does not reduce serum porphyrin levels in porphyria cutanea tarda.
    Hebert AA; Farmer KL; Poh-Fitzpatrick MB
    Nephron; 1992; 60(2):240. PubMed ID: 1553013
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunochemical parameters and blood-letting therapy in porphyria cutanea tarda (author's transl)].
    Schwartze G; Kühn G
    Dermatol Monatsschr; 1980 Jan; 166(1):19-23. PubMed ID: 7398963
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection.
    Ratnaike S; Blake D; Campbell D; Cowen P; Varigos G
    Australas J Dermatol; 1988 Apr; 29(1):3-8. PubMed ID: 3250437
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of a case of porphyria cutanea tarda by plasmapheresis].
    Dupré A; Bonafé JL; Callot JP; Campardou AM; Nabulsi-Kassas M; Snapir G; Augustin C
    Ann Dermatol Venereol; 1980 Jul; 107(7):693-5. PubMed ID: 7436265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum vitamin E, cholesterol and triglyceride concentrations in patients with acute hepatic porphyria and porphyria cutanea tarda].
    Ostrowski J; Kostrzewska E; Błaszczyk M
    Pol Tyg Lek; 1984 Jan; 39(3):87-9. PubMed ID: 6739355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic discoid erythematosus and porphyria cutanea tarda].
    Malina L; Jíra M
    Cas Lek Cesk; 1987 Dec; 126(52):1620-3. PubMed ID: 3442789
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of the treatment of porphyria cutanea tarda by plasmapheresis].
    Gasior-Chrzan B; Wasik F; Partyka T; Gamin E
    Przegl Dermatol; 1985; 72(3):294-7. PubMed ID: 3909235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carbohydrate metabolic disorders in porphyria cutanea tarda].
    Naĭdenov E; Ivanov E; Polonov K; Tŭrkolev N; Adzharov D
    Vutr Boles; 1987; 26(4):62-5. PubMed ID: 3673037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda.
    Kalb RE; Grossman ME; Poh-Fitzpatrick MB
    Arch Dermatol; 1985 Oct; 121(10):1289-91. PubMed ID: 4037823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of plasma uroporphyrin during treatment and long-term follow-up of patients with Porphyria cutanea tarda.
    Adjarov DG; Kerimova MA
    Clin Chim Acta; 1989 May; 181(2):143-50. PubMed ID: 2736777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and biochemical findings in patients with porphyria cutanea tarda.
    Błaszczyk M; Daoud S; Chorzelski T; Jabłońska S; Sulej J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):757-62. PubMed ID: 7349094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology of porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1982 Jul; (7):19-23. PubMed ID: 7136251
    [No Abstract]   [Full Text] [Related]  

  • 14. Heme-mediated modulation of alpha-globin chain biosynthesis in porphyria cutanea tarda associated with heterozygous beta-thalassemia.
    Gambari R; Buzzoni D; Barbieri R; Perrotta C; Piva R; Conconi F; del Senno L; Ogier C
    Haematologica; 1988; 73(1):13-9. PubMed ID: 3131199
    [No Abstract]   [Full Text] [Related]  

  • 15. [A decrease in plasma sodium ion during the course of an acute attack of porphyria].
    Zienkiewicz K; Kostrzewska E; Gregor A; Osiński J
    Pol Tyg Lek; 1989 Sep 4-25; 44(36-39):834-5. PubMed ID: 2486516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose tolerance in adult Ethiopian patients with liver disease and porphyria cutanea tarda.
    Mengistu M; Gebreselassie F; Tsega E
    Ethiop Med J; 1989 Jul; 27(3):107-14. PubMed ID: 2753029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of porphyria hepatica cutanea tarda by bloodletting (experience in 10 cases)].
    García Plaza A; España Saz P; Escartín Marín P; Diego Marín FJ; Criado Ortiz M
    Rev Clin Esp; 1973 Dec; 131(6):477-84. PubMed ID: 4780002
    [No Abstract]   [Full Text] [Related]  

  • 19. Small volume plasmapheresis in the management of porphyria cutanea tarda.
    Miyauchi S; Shiraishi S; Miki Y
    Arch Dermatol; 1983 Sep; 119(9):752-5. PubMed ID: 6614963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoelectrophoretic studies in late cutaneous porphyria].
    Kipping D; Barth J; Petter O
    Dermatol Monatsschr; 1972 Dec; 158(12):873-7. PubMed ID: 4123497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.